Yum S - Search Results

1

Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement.

Yum S, Jeong S, Lee S, Nam J, Kim W, Yoo JW, Kim MS, Lee BL, Jung Y. Yum S, et al. Drug Des Devel Ther. 2015 Aug 4;9:4247-58. doi: 10.2147/DDDT.S88670. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26273188 Free PMC article.

2

Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.

Jeong S, Park H, Hong S, Yum S, Kim W, Jung Y. Jeong S, et al. Among authors: yum s. Eur J Pharmacol. 2015 Jan 15;747:114-22. doi: 10.1016/j.ejphar.2014.11.030. Epub 2014 Dec 4. Eur J Pharmacol. 2015. PMID: 25483211

3

HIF-prolyl hydroxylase is a potential molecular target for esculetin-mediated anti-colitic effects.

Yum S, Jeong S, Lee S, Kim W, Nam J, Jung Y. Yum S, et al. Fitoterapia. 2015 Jun;103:55-62. doi: 10.1016/j.fitote.2015.03.013. Epub 2015 Mar 20. Fitoterapia. 2015. PMID: 25797536

4

Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.

Hong S, Yum S, Yoo HJ, Kang S, Yoon JH, Min D, Kim YM, Jung Y. Hong S, et al. Among authors: yum s. Mol Pharm. 2012 May 7;9(5):1310-9. doi: 10.1021/mp200591q. Epub 2012 Mar 27. Mol Pharm. 2012. PMID: 22428658

5

Piceatannol, a hydroxystilbene natural product, stabilizes HIF-1α protein by inhibiting HIF prolyl hydroxylase.

Yum S, Doh HJ, Hong S, Jeong S, Kim DD, Park M, Jung Y. Yum S, et al. Eur J Pharmacol. 2013 Jan 15;699(1-3):124-31. doi: 10.1016/j.ejphar.2012.12.008. Epub 2012 Dec 19. Eur J Pharmacol. 2013. PMID: 23261967

6

Dithiocarbamate chitosan as a potential polymeric matrix for controlled drug release.

Kim YT, Yum S, Heo JS, Kim W, Jung Y, Kim YM. Kim YT, et al. Among authors: yum s. Drug Dev Ind Pharm. 2014 Feb;40(2):192-200. doi: 10.3109/03639045.2012.753900. Epub 2013 Jan 16. Drug Dev Ind Pharm. 2014. PMID: 23323844

7

Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation.

Kim H, Kim W, Yum S, Hong S, Oh JE, Lee JW, Kwak MK, Park EJ, Na DH, Jung Y. Kim H, et al. Among authors: yum s. Free Radic Biol Med. 2013 Dec;65:552-562. doi: 10.1016/j.freeradbiomed.2013.07.015. Epub 2013 Jul 26. Free Radic Biol Med. 2013. PMID: 23892357

8

N-(2-Mercaptopropionyl)-glycine, a diffusible antioxidant, activates HIF-1 by inhibiting HIF prolyl hydroxylase-2: implication in amelioration of rat colitis by the antioxidant.

Yum S, Park H, Hong S, Jeong S, Kim W, Jung Y. Yum S, et al. Biochem Biophys Res Commun. 2014 Jan 17;443(3):1008-13. doi: 10.1016/j.bbrc.2013.12.081. Epub 2013 Dec 19. Biochem Biophys Res Commun. 2014. PMID: 24361888

9

Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase.

Yum S, Jeong S, Kim D, Lee S, Kim W, Yoo JW, Kim JA, Kwon OS, Kim DD, Min DS, Jung Y. Yum S, et al. Int J Mol Sci. 2017 Dec 25;19(1):53. doi: 10.3390/ijms19010053. Int J Mol Sci. 2017. PMID: 29295567 Free PMC article.

10

Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: a potential pharmacologic mechanism and therapeutic advantages.

Lee Y, Kim W, Hong S, Park H, Yum S, Yoon JH, Jung Y. Lee Y, et al. Among authors: yum s. Eur J Pharmacol. 2014 Mar 5;726:49-56. doi: 10.1016/j.ejphar.2014.01.011. Eur J Pharmacol. 2014. PMID: 24462351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters